Company Filing History:
Years Active: 1991
Title: King S Lam: Innovator in Antitumor Antibiotics
Introduction
King S Lam is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor antibiotics. His innovative work has the potential to impact cancer treatment positively.
Latest Patents
King S Lam holds a patent for a new antitumor antibiotic designated BMY-40800. This compound is produced through the fermentation of Streptomyces hygroscopicus ATCC 53653. The BMY-40800 antibiotic has shown promising results in inhibiting the growth of tumors in experimental animals. This advancement represents a significant step forward in cancer research and treatment.
Career Highlights
Throughout his career, King S Lam has been associated with Bristol-Myers Company, where he has contributed to various research initiatives. His work has focused on developing effective treatments for cancer, showcasing his dedication to improving patient outcomes.
Collaborations
King S Lam has collaborated with several esteemed colleagues, including Jacqueline M Mattei and John E Leet. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
King S Lam's contributions to the field of antitumor antibiotics exemplify his commitment to advancing medical science. His work continues to inspire future innovations in cancer treatment.